Riverview Trust Company’s Thermo Fisher Scientific TMO Stock Holding History

Riverview Trust Company’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-139	Closed	-$69.2K	–	549
2025 Q1	$69.2K	Buy	139 +74	+114%	+$40.1K	0.07%	183
2024 Q4	$33.8K	Sell	65 -151	-70%	-$83K	0.03%	285
2024 Q3	$134K	Buy	216 +7	+3%	+$4.14K	0.12%	130
2024 Q2	$116K	Buy	209 +70	+50%	+$40.1K	0.11%	143
2024 Q1	$80.8K	Buy	+139	New	+$78K	0.06%	186
2023 Q4	–	Sell	-264	Closed	-$134K	–	581
2023 Q3	$134K	Sell	264 -120	-31%	-$63.9K	0.12%	122
2023 Q2	$200K	Hold	384	–	–	0.18%	89
2023 Q1	$221K	Hold	384	–	–	0.2%	84
2022 Q4	$211K	Sell	384 -439	-53%	-$233K	0.2%	85
2022 Q3	$417K	Sell	823 -11	-1%	-$6.16K	0.4%	50
2022 Q2	$453K	Buy	834 +113	+16%	+$62.2K	0.39%	51
2022 Q1	$426K	Buy	721 +278	+63%	+$160K	0.32%	53
2021 Q4	$296	Hold	443	–	–	0.17%	70
2021 Q3	$253K	Hold	443	–	–	0.27%	70
2021 Q2	$223K	Hold	443	–	–	0.24%	77
2021 Q1	$202K	Hold	443	–	–	0.23%	79
2020 Q4	$206K	Hold	443	–	–	0.23%	76
2020 Q3	$196K	Sell	443 -589	-57%	-$243K	0.23%	76
2020 Q2	$374K	Hold	1,032	–	–	0.36%	53
2020 Q1	$293K	Sell	1,032 -403	-28%	-$127K	0.28%	65
2019 Q4	$466K	Hold	1,435	–	–	0.31%	59
2019 Q3	$418K	Hold	1,435	–	–	0.29%	67
2019 Q2	$421K	Hold	1,435	–	–	0.3%	65
2019 Q1	$393K	Hold	1,435	–	–	0.3%	68
2018 Q4	$321K	Buy	+1,435	New	+$337K	0.25%	72

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Riverview Trust Company's TMO Position: Q2 2025 in Review

Riverview Trust Company sold out of Thermo Fisher Scientific (TMO) in Q2 2025, closing a stake of 139 shares — an estimated $69.2K sold.

Riverview Trust Company first reported a position in TMO in Q4 2018 and held it in 25 quarters. The position peaked at $466K in Q4 2019. 2,453 funds tracked by Wall St. Rank hold TMO as of Q2 2025.

Riverview Trust Company reported no remaining Thermo Fisher Scientific position as of Q2 2025 after selling out during the quarter.
Riverview Trust Company sold 139 Thermo Fisher Scientific shares in Q2 2025, an estimated $69.2K.
Riverview Trust Company first reported a position in Thermo Fisher Scientific in Q4 2018 and held it in 25 quarters.
Riverview Trust Company's Thermo Fisher Scientific position peaked at $466K in Q4 2019.
2,453 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2025.

Based on Riverview Trust Company's 13F filing for Q2 2025, filed 21 Jul 2025.